RS Investment Management’s West Pharmaceutical WST Stock Holding History

RS Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$95.1M	Sell	1,253,102 -333,431	-21%	-$24.3M	0.98%	17
2016 Q1	$110M	Sell	1,586,533 -335,162	-17%	-$20.2M	1.09%	12
2015 Q4	$116M	Buy	1,921,695 +136,400	+8%	+$8.21M	1.04%	17
2015 Q3	$96.6M	Buy	1,785,295 +253,234	+17%	+$14.8M	0.86%	23
2015 Q2	$89M	Sell	1,532,061 -402,558	-21%	-$22.5M	0.76%	33
2015 Q1	$116M	Sell	1,934,619 -66,871	-3%	-$3.56M	1.04%	8
2014 Q4	$106M	Buy	2,001,490 +478,014	+31%	+$23.9M	0.95%	15
2014 Q3	$68.2M	Buy	1,523,476 +135,960	+10%	+$5.78M	0.63%	50
2014 Q2	$58.5M	Buy	1,387,516 +510,757	+58%	+$21.9M	0.49%	74
2014 Q1	$38.6M	Sell	876,759 -64,213	-7%	-$3.02M	0.23%	137
2013 Q4	$46.2M	Buy	940,972 +1,140	+0.1%	+$53.4K	0.28%	115
2013 Q3	$38.7M	Buy	939,832 +615,672	+190%	+$23.5M	0.25%	121
2013 Q2	$11.4M	Buy	+324,160	New	+$10.7M	0.08%	195

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

RS Investment Management's WST Position: Q2 2016 in Review

RS Investment Management reduced its West Pharmaceutical (WST) stake by 21% in Q2 2016, selling an estimated $24.3M and leaving 1,253,102 shares worth $95.1M. The position accounts for 0.98% of the portfolio, ranked #17.

RS Investment Management first reported a position in WST in Q2 2013 and has held it in 13 quarters since. The position peaked at $116M in Q1 2015. 289 funds tracked by Wall St. Rank hold WST as of Q2 2016.

RS Investment Management held 1,253,102 shares of West Pharmaceutical worth $95.1M as of Q2 2016.
RS Investment Management sold 333,431 West Pharmaceutical shares in Q2 2016, an estimated $24.3M.
West Pharmaceutical made up 0.98% of RS Investment Management's portfolio in Q2 2016, its #17 holding.
RS Investment Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 13 quarters since.
RS Investment Management's West Pharmaceutical position peaked at $116M in Q1 2015.
289 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.